Minimed S.R.L.
- Address
- Strada Pacii Nr.7, 600274 Bacau, Romania
Minimed S.R.L. - Metabolic and Cardiovascular Research Center
Minimed S.R.L. is a specialized clinical research center focused on advancing therapeutic approaches for metabolic disorders and cardiovascular disease prevention. The center demonstrates particular expertise in diabetes management, obesity treatment, and heart failure prevention, conducting pivotal Phase III trials that evaluate novel pharmaceutical interventions and combination therapies.
- Prevention of heart failure and cardiovascular death in high-risk populations using innovative combination therapies
- Type 1 and Type 2 diabetes management, including next-generation insulin formulations and oral therapeutic agents
- Obesity and overweight treatment, including investigations in patients with knee osteoarthritis
The research center's portfolio includes groundbreaking studies comparing once-weekly insulin formulations to traditional daily regimens in Type 1 diabetes patients, as well as evaluating oral orforglipron against insulin glargine in Type 2 diabetes patients with elevated cardiovascular risk. Minimed S.R.L. plays a crucial role in developing evidence for emerging therapies that address the complex intersection of metabolic syndrome, obesity, and cardiovascular complications, contributing to the advancement of personalized treatment strategies for patients with these interconnected conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1AstraZeneca AB2active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Minimed S.R.L.
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Comparison of Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 with Insulin Aspart in Adults with Type 1 Diabetes | Novo Nordisk A/S | Phase III | Not Recruiting | Aug 2025 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 2 | Unknown | 2023-08-02 | 2025-05-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.